Prospects of therapies targeting resistant bacteria-New challenges 20 years post emergence of vancomycin-resistant enterococcus

Current Opinion in Microbiology

Volumn 10, Issue 5, 2007, Pages 425-427

  Brickner, Steven J ^a   Mobashery, Shahriar ^b  

^a PFIZER INC   (United States)

^b UNIVERSITY OF NOTRE DAME   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MACROLIDE; PANTON VALENTINE LEUKOCIDIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; STREPTOCOCCUS VACCINE; VANCOMYCIN;

ACINETOBACTER BAUMANNII; DRUG INDUSTRY; EDITORIAL; ENTEROCOCCAL INFECTION; ENTEROCOCCUS FAECIUM; GENE TRANSFER; IMMUNIZATION; IMMUNOCOMPROMISED PATIENT; METHICILLIN RESISTANT PSEUDOMONAS AERUGINOSA; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STREPTOCOCCUS PNEUMONIAE; MOLECULAR THERAPY; MULTIDRUG RESISTANCE; NONHUMAN; PENICILLIN RESISTANCE; PHYSICIAN; PSEUDOMONAS AERUGINOSA; VANCOMYCIN RESISTANT ENTEROCOCCUS;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; DRUG RESISTANCE, BACTERIAL; ENTEROCOCCUS; HUMANS; VANCOMYCIN RESISTANCE;

ENTEROCOCCUS;

EID: 35748981467     PISSN: 13695274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mib.2007.09.002     Document Type: Editorial

References (0)